Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells

Features and development of Coot

Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. D. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 27,510 · see citing works

<i>PHENIX</i> : a comprehensive Python-based system for macromolecular structure solution

Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716 · see citing works

<i>XDS</i>

Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463 · see citing works

<i>MolProbity</i> : all-atom structure validation for macromolecular crystallography

Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115 · see citing works

Inference of macromolecular assemblies from crystalline state.

Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 10,189 · see citing works

UCSF ChimeraX : Structure visualization for researchers, educators, and developers

Pettersen, E. F., Goddard, T. D., Huang, C. C., Meng, E. C., Couch, G. S., Croll, T. I., Morris, J. H., & Ferrin, T. E. (2020) · Protein Science · doi:10.1002/pro.3943 · Cited by 9,327 · see citing works

DNA targeting specificity of RNA-guided Cas9 nucleases

Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741 · see citing works

Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9

Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637 · see citing works

Enhancement of Antitumor Immunity by CTLA-4 Blockade

Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955 · see citing works

High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects

Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673 · see citing works

Rationally engineered Cas9 nucleases with improved specificity

Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414 · see citing works

GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases

Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268 · see citing works

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · see citing works

Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements

Kosicki, M., Tomberg, K., & Bradley, A. (2018) · Nature Biotechnology · doi:10.1038/nbt.4192 · Cited by 1,883 · see citing works

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

Eyquem, J., Mansilla-Soto, J., Giavridis, T., van der Stegen, S. J. C., Hamieh, M., Cunanan, K. M., Odak, A., Gönen, M., & Sadelain, M. (2017) · Nature · doi:10.1038/nature21405 · Cited by 1,831 · see citing works

Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

Hu, J. H., Miller, S. M., Geurts, M. H., Tang, W., Chen, L., Sun, N., Zeina, C. M., Gao, X., Rees, H. A., Lin, Z., et al. (2018) · Nature · doi:10.1038/nature26155 · Cited by 1,552 · see citing works

Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease

Anders, C., Niewoehner, O., Duerst, A., & Jínek, M. (2014) · Nature · doi:10.1038/nature13579 · Cited by 1,319 · see citing works

Enhanced proofreading governs CRISPR-Cas9 targeting accuracy

Chen, J. S., Dagdas, Y. S., Kleinstiver, B. P., Welch, M. M., Sousa, A. A., Harrington, L. B., Sternberg, S. H., Joung, J. K., Yildiz, A., & Doudna, J. A. (2017) · Nature · doi:10.1038/nature24268 · Cited by 1,168 · see citing works

A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells

Vakulskas, C. A., Dever, D. P., Rettig, G. R., Turk, R., Jacobi, A. M., Collingwood, M. A., Bode, N. M., McNeill, M. S., Yan, S., Camarena, J., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0137-0 · Cited by 782 · see citing works

CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences

Lin, Y., Cradick, T. J., Brown, M. T., Deshmukh, H., Ranjan, P., Sarode, N., Wile, B. M., Vertino, P. M., Stewart, F. J., & Bao, G. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku402 · Cited by 634 · see citing works

Programmable RNA recognition and cleavage by CRISPR/Cas9

O’Connell, M. R., Oakes, B. L., Sternberg, S. H., East-Seletsky, A., Kaplan, M., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13769 · Cited by 631 · see citing works

Conformational control of DNA target cleavage by CRISPR–Cas9

Sternberg, S. H., LaFrance, B., Kaplan, M., & Doudna, J. A. (2015) · Nature · doi:10.1038/nature15544 · Cited by 627 · see citing works

A Cas9–guide RNA complex preorganized for target DNA recognition

Jiang, F., Zhou, K., Ma, L., Gressel, S., & Doudna, J. A. (2015) · Science · doi:10.1126/science.aab1452 · Cited by 551 · see citing works

Directed evolution of CRISPR-Cas9 to increase its specificity

Lee, J. K., Jeong, E., Lee, J., Jung, M., Shin, E., Kim, Y.-H., Lee, K., Jung, I., Kim, D., Kim, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05477-x · Cited by 525 · see citing works

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing

Yin, H., Song, C.-Q., Suresh, S., Wu, Q., Walsh, S., Rhym, L. H., Mintzer, E., Bolukbasi, M. F., Zhu, L. J., Kauffman, K., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.4005 · Cited by 499 · see citing works

A highly specific SpCas9 variant is identified by in vivo screening in yeast

Casini, A., Olivieri, M., Petris, G., Montagna, C., Reginato, G., Maule, G., Lorenzin, F., Prandi, D., Romanel, A., Demichelis, F., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4066 · Cited by 493 · see citing works

DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks

van Overbeek, M., Capurso, D., Carter, M. M., Thompson, M. S., Frias, E., Russ, C., Reece-Hoyes, J. S., Nye, C., Gradia, S., Vidal, B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.06.037 · Cited by 454 · see citing works

The Emerging Landscape of Immune Cell Therapies

Weber, E. W., Maus, M. V., & Mackall, C. L. (2020) · Cell · doi:10.1016/j.cell.2020.03.001 · Cited by 445 · see citing works

Mapping the genomic landscape of CRISPR-Cas9 cleavage

Cameron, P., Fuller, C. K., Donohoue, P. D., Jones, B. N., Thompson, M. S., Carter, M. M., Gradia, S., Vidal, B., Garner, E., Slorach, E. M., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4284 · Cited by 443 · see citing works

Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq

Wienert, B., Wyman, S. K., Richardson, C. D., Yeh, C. D., Akcakaya, P., Porritt, M. J., Morlock, M., Vu, J. T., Kazane, K. R., Watry, H. L., et al. (2019) · Science · doi:10.1126/science.aav9023 · Cited by 434 · see citing works

Increasing the specificity of CRISPR systems with engineered RNA secondary structures

Kocak, D. D., Josephs, E. A., Bhandarkar, V., Adkar, S. S., Kwon, J. B., & Gersbach, C. A. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0095-1 · Cited by 351 · see citing works

Web 3DNA 2.0 for the analysis, visualization, and modeling of 3D nucleic acid structures

Li, S., Olson, W. K., & Lu, X. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz394 · Cited by 333 · see citing works

CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome

Shin, H. Y., Wang, C., Lee, H., Yoo, K. H., Zeng, X., Kuhns, T. M., Yang, C. M., Mohr, T., Liu, C., & Hennighausen, L. G. (2017) · Nature Communications · doi:10.1038/ncomms15464 · Cited by 303 · see citing works

A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9

Dagdas, Y. S., Chen, J. S., Sternberg, S. H., Doudna, J. A., & Yildiz, A. (2017) · Science Advances · doi:10.1126/sciadv.aao0027 · Cited by 293 · see citing works

Partial DNA-guided Cas9 enables genome editing with reduced off-target activity

Yin, H., Song, C.-Q., Suresh, S., Kwan, S.-Y., Wu, Q., Walsh, S., Ding, J., Bogorad, R. L., Zhu, L. J., Wolfe, S. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2559 · Cited by 240 · see citing works

Highly Parallel Profiling of Cas9 Variant Specificity

Schmid-Burgk, J. L., Gao, L., Li, D., Gardner, Z., Strecker, J., Lash, B., & Zhang, F. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.02.023 · Cited by 197 · see citing works

A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

Pomeroy, E. J., Hunzeker, J., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C.-L., Yamamoto, K., Bendzick, L. E., Miller, J. S., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.10.009 · Cited by 196 · see citing works

High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding

Boyle, E. A., Andreasson, J. O. L., Chircus, L. M., Sternberg, S. H., Wu, M. J., Guegler, C. K., Doudna, J. A., & Greenleaf, W. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700557114 · Cited by 195 · see citing works

Allele-specific gene editing prevents deafness in a model of dominant progressive hearing loss

György, B., Nist-Lund, C. A., Pan, B., Asai, Y., Karavitaki, K. D., Kleinstiver, B. P., Garcia, S. P., Zaborowski, M. P., Solanes, P., Spataro, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0500-9 · Cited by 192 · see citing works

Incorporation of bridged nucleic acids into CRISPR RNAs improves Cas9 endonuclease specificity

Cromwell, C. R., Sung, K., Park, J., Krysler, A. R., Jovel, J., Kim, S. K., & Hubbard, B. P. (2018) · Nature Communications · doi:10.1038/s41467-018-03927-0 · Cited by 190 · see citing works

Evaluating and enhancing target specificity of gene-editing nucleases and deaminases

Kim, D., Luk, K., Wolfe, S. A., & Kim, J.-S. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-013118-111730 · Cited by 171 · see citing works

Cryo-EM structures reveal coordinated domain motions that govern DNA cleavage by Cas9

Zhu, X. Q., Clarke, R., Puppala, A. K., Chittori, S., Merk, A., Merrill, B. J., Simonović, M., & Subramaniam, S. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0258-2 · Cited by 154 · see citing works

Enhancement of target specificity of CRISPR–Cas12a by using a chimeric DNA–RNA guide

Kim, H., Lee, W.-J., Oh, Y., Kang, S.-H., Hur, J., Lee, H. K., Song, W.-J., Lim, K., Park, Y.-H., Song, B., et al. (2020) · bioRxiv · doi:10.1093/nar/gkaa605 · Cited by 138 · see citing works

Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells

Hung, K. L., Meitlis, I., Hale, M. R., Chen, C., Singh, S., Jackson, S. W., Miao, C. H., Khan, I., Rawlings, D. J., & James, R. G. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.012 · Cited by 137 · see citing works

A crystallographic map of the transition from B-DNA to A-DNA

Vargason, J. M., Henderson, K., & Ho, P. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121176898 · Cited by 125 · see citing works

A method for the analysis of domain movements in large biomolecular complexes

Poornam, G., Matsumoto, A., Ishida, H., & Hayward, S. (2008) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22339 · Cited by 109 · see citing works

Engineered CRISPR/Cas9 enzymes improve discrimination by slowing DNA cleavage to allow release of off-target DNA

Liu, M., Gong, S., Yu, H., Jung, K., Johnson, K. A., & Taylor, D. W. (2020) · Nature Communications · doi:10.1038/s41467-020-17411-1 · Cited by 100 · see citing works

Ready for Repair? Gene Editing Enters the Clinic for the Treatment of Human Disease

Ernst, M. P. T., Broeders, M., Herrero-Hernandez, P., Oussoren, E., van der Ploeg, A. T., & Pijnappel, W. W. M. P. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.06.022 · Cited by 99 · see citing works

Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders

Christie, K. A., Courtney, D., DeDionisio, L., Chao-Shern, C., Majumdar, S. D., Mairs, L., Nesbit, M. A., & Moore, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-16279-4 · Cited by 82 · see citing works

Conformational states of Cas9-sgRNA-DNA ternary complex in the presence of magnesium

Zhu, X. Q., Clarke, R., Puppala, A. K., Chittori, S., Merk, A., Merrill, B. J., Simonović, M., & Subramaniam, S. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6o0z/pdb · Cited by 81 · see citing works

Lessons from Enzyme Kinetics Reveal Specificity Principles for RNA-Guided Nucleases in RNA Interference and CRISPR-Based Genome Editing

Bisaria, N., Jarmoskaite, I., & Herschlag, D. (2017) · Cell Systems · doi:10.1016/j.cels.2016.12.010 · Cited by 72 · see citing works

Mapping the sugar dependency for rational generation of a DNA-RNA hybrid-guided Cas9 endonuclease

Rueda, F. O., Biśta, M., Newton, M. D., Goeppert, A. U., Cuomo, M. E., Gordon, E., Kroener, F., Read, J. A., Wrigley, J. D. J., Rueda, D., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01732-9 · Cited by 69 · see citing works

Structural insights into a high fidelity variant of SpCas9

Guo, M., Ren, K., Zhu, Y., Tang, Z., Wang, Y., Zhang, B., & Huang, Z. (2019) · Cell Research · doi:10.1038/s41422-018-0131-6 · Cited by 65 · see citing works

Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity

O’Reilly, D., Kartje, Z. J., Ageely, E. A., Malek-Adamian, E., Habibian, M., Schofield, A., Barkau, C. L., Rohilla, K. J., DeRossett, L. B., Weigle, A. T., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1214 · Cited by 61 · see citing works

Chimeric Guides Probe and Enhance Cas9 Biochemical Activity

Kartje, Z. J., Barkau, C. L., Rohilla, K. J., Ageely, E. A., & Gagnon, K. T. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00107 · Cited by 50 · see citing works

Allele-specific genome targeting in the development of precision medicine

Wu, J., Tang, B., & Tang, Y. (2020) · Theranostics · doi:10.7150/thno.43298 · Cited by 38 · see citing works

Crystal structure of xCas9 in complex with sgRNA and target DNA (AAG PAM)

Guo, M., Ren, K., Zhu, Y., & Huang, Z. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6aeb/pdb · Cited by 37 · see citing works

Improved Cas9 activity by specific modifications of the tracrRNA

Scott, T. A., Urak, R. Z., Soemardy, C., & Morris, K. V. (2019) · Scientific Reports · doi:10.1038/s41598-019-52616-5 · Cited by 35 · see citing works

Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease

Chen, W., Zhang, H., Zhang, Y., Wang, Y., Gan, J., & Ji, Q. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000496 · Cited by 30 · see citing works

Chimeric crRNAs with 19 DNA residues in the guide region show the retained DNA cleavage activity of Cas9 with potential to improve the specificity

Kim, H. Y., Kang, S. J., Jeon, Y., An, J., Park, J., Lee, H. J., Jang, J.-E., Ahn, J., Bang, D., Chung, H. S., et al. (2019) · Chemical Communications · doi:10.1039/c8cc08468h · Cited by 18 · see citing works

Past, present, and future of CRISPR genome editing technologies

Pacesa, M., Pelea, O., & Jinek, M. (2024) · Cell · doi:10.1016/j.cell.2024.01.042 · Cited by 609 · see citing works

Structural basis for Cas9 off-target activity

Pacesa, M., Lin, C.-H., Cléry, A., Saha, A., Arantes, P. R., Bargsten, K., Irby, M. J., Allain, F. H.-T., Palermo, G., Cameron, P., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.026 · Cited by 198 · see citing works

Design of highly functional genome editors by modeling the universe of CRISPR-Cas sequences

Ruffolo, J. A., Nayfach, S., Gallagher, J., Bhatnagar, A., Beazer, J., Hussain, R., Russ, J., Yip, J., Hill, E., Pacesa, M., et al. (2024) · doi:10.1101/2024.04.22.590591 · Cited by 90 · see citing works

Emerging applications of gene editing technologies for the development of climate-resilient crops

Chavhan, R. L., Jaybhaye, S. G., Hinge, V. R., Deshmukh, A. S., Shaikh, U. S., Jadhav, P. K., Kadam, U. S., & Hong, J. C. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1524767 · Cited by 43 · see citing works

Prediction of off-target effects of the CRISPR/Cas9 system for design of sgRNA

Guo, C., & Zhen, D. (2020) · E3S Web of Conferences · doi:10.1051/e3sconf/202018504018

Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field

He, Z., Men, K., Qin, Z., Yang, Y., Xu, T., & Wei, Y.-Q. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9033-0 · Cited by 53 · see citing works

Cas9 Cuts and Consequences; Detecting, Predicting, and Mitigating CRISPR/Cas9 On‐ and Off‐Target Damage

Newman, A., Starrs, L. M., & Burgio, G. (2020) · BioEssays · doi:10.1002/bies.202000047 · Cited by 23 · see citing works

[Research progress of CRISPR-Cas9 system for gene therapy].

Zhan, C., & Xia, X. (2016) · PubMed · doi:10.13345/j.cjb.150542 · Cited by 7 · see citing works

The CRISPR/Cas9 system forms a condensate in the yeast nucleus

Medina‐Suárez, S., & Machín, F. (2023) · PubMed · doi:10.17912/micropub.biology.001039